Clinical Trials Logo

Clinical Trial Summary

The main purpose of this study is to see if there is clinical benefit of using Biovance in reduction of the recurrence of keloids when used to revise them. It will also assess the postoperative complications.


Clinical Trial Description

To assess the performance of Biovance, patients will consulted regarding the history and previous treatment of their keloid. Once patients are deemed to be appropriate candidates, they will be enrolled in the study. Operatively, the old scar will be completely excised. Then the Biovance will be laid in the base of the wound. After this is performed, extensive undermining will be done to close the wound in layers.

All post-revision complications (including infection, incision dehiscence, hematoma, seroma, and wound necrosis) will be assessed and recorded by the investigator. Patients will be reviewed to obtain demographic and risk factor (such as age, body mass index, smoking) data. Data on adjuvant therapy use (previous surgeries, treatments for keloid scar) will be collected. Surgical technique details (such as incision size and closure technique) will also be recorded for each patient. Photographs documenting the pre-, intra- and post-revision clinical course of patients will be collected. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02521402
Study type Interventional
Source Golla Center for Plastic Surgery
Contact Dinakar Golla, MD
Phone 412-963-6677
Email drgolla@gollaplasticsurgery.com
Status Not yet recruiting
Phase Phase 4
Start date August 2015
Completion date June 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03693924 - A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Keloid Scars.
Completed NCT04016610 - Proof of Concept (POC) Study of the Soliton's Acoustic Scar Reduction (ASR) Treatment for the Treatment of Keloid Scar N/A
Completed NCT04786210 - Treatment of Keloids With Fractional Erbium Laser-Assisted 5-Fluorouracil Versus Laser-Assisted Corticosteroid Phase 4
Active, not recruiting NCT01736969 - A Substantial Equivalence Study of RD04723 and Predicate Device N/A
Completed NCT01176877 - Assessing and Improving Patient Knowledge About Keloid Scars (Keloids) N/A
Recruiting NCT04184011 - Superficial Radiation Therapy (SRT) for the Treatment of Recurrent Keloid Scars
Withdrawn NCT01295099 - Keloid Scarring: Treatment and Pathophysiology Phase 4